Product Code: GVR-1-68038-426-0
Coronary Artery Bypass Graft Market Growth & Trends:
The global coronary artery bypass graft market size is expected to reach USD 24.06 billion by 2030, registering a CAGR of 9.4% from 2024 to 2030, based on a new report by Grand View Research, Inc. The primary factor driving the industry is an increase in the prevalence of hypertension and cases of myocardial infarction. The American Heart Association estimated that in 2020, Coronary Heart Disease (CHD) was the leading cause of death in the U.S. In addition, the rising technological advancements have led to the development of endoscopic bypass surgery that offers various benefits compared to traditional bypass surgery. Such kind of advancements are contributing to the market growth. Furthermore, the rising geriatric population is influencing market growth.
The aged population is more prone to coronary artery blockages, and studies show that the average age of people undergoing Coronary Artery Bypass Graft (CABG) procedures is approximately older than 66 years. The COVID-19 pandemic had a negative impact on many industries and the CABG market was also highly affected. A study published by the University of Alabama at Birmingham shows an approximately 36% decline in patients undergoing bypass surgery. Many routine procedures were limited due to a workforce shortage. In addition, the supply of raw materials for the devices was limited in the initial phase of COVID-19. Thus, the above-mentioned factors lowered the manufacturing and production of devices.
Coronary Artery Bypass Graft Market Report Highlights:
- The off-pump segment accounted for the largest revenue share of over 53.6% in 2023
- In 2023, North America dominated the global market and accounted for a revenue share of 47.5%. This growth can be attributed to a rise in cardiovascular cases across the region
- By methods, the off-pump segment dominated the market and accounted for a revenue share of 53.6% in 2023. This growth can be attributed to various benefits associated with the product, such as small incisions, faster recovery, and shorter hospital stay
- The single CABG surgery procedure segment dominated the industry and accounted for a revenue share of 32.9% in 2023. The segment also expected to grow at the fastest CAGR over the forecast period
- The hospital end-use segment dominated the market and accounted for a revenue share of 52.6% in 2023
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Method Segment
- 1.1.1.2. Surgical Procedure Segment
- 1.1.1.3. End use segment
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Primary Sources
- 1.11. List of Abbreviations
Chapter 2. Coronary Artery Bypass Graft Market: Executive Summary
- 2.1. Market Snapshot
- 2.2. Method and Surgical Procedure Snapshots
- 2.3. End Use Snapshot
- 2.4. Competitive Landscape Snapshot
Chapter 3. Coronary Artery Bypass Graft Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.4. Market Drivers Analysis
- 3.4.1. Increasing in prevalence of cardiovascular diseases
- 3.4.2. Growing prevalence of hypertension
- 3.4.3. Rising technological advancement
- 3.4.4. Favorable reimbursement scenario
- 3.5. Market Restraint Analysis
- 3.5.1. Shortage of skilled workforce
- 3.5.2. Complications/Risks associated with the surgery
- 3.6. Coronary Artery Bypass Graft Market Analysis Tools
- 3.6.1. Industry Analysis - Porter's
- 3.6.1.1. Supplier Power
- 3.6.1.2. Buyer Power
- 3.6.1.3. Substitution Threat
- 3.6.1.4. Threat of New Entrant
- 3.6.1.5. Competitive Rivalry
- 3.6.2. PESTLE Analysis
- 3.6.2.1. Political Landscape
- 3.6.2.2. Technological Landscape
- 3.6.2.3. Economic Landscape
- 3.6.3. Pricing Analysis
Chapter 4. Coronary Artery Bypass Graft Market: Method Estimates & Trend Analysis
- 4.1. Method Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Coronary Artery Bypass Graft Market by Method Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For the Following
- 4.4.1. Off-pump
- 4.4.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2. On-pump
- 4.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.3. Minimally Invasive Direct
- 4.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 5. Coronary Artery Bypass Graft Market: Surgical Procedure Estimates & Trend Analysis
- 5.1. Surgical Procedure Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Coronary Artery Bypass Graft Market by Surgical Procedure Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For The Following
- 5.4.1. Single CABG surgery
- 5.4.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.4.2. Double CABG surgery
- 5.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.4.3. Triple CABG surgery
- 5.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.4.4. Quadruple CABG surgery
- 5.4.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 6. Coronary Artery Bypass Graft Market: End use Estimates & Trend Analysis
- 6.1. End Use Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Coronary Artery Bypass Graft Market by End use Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For the Following
- 6.4.1. Hospitals
- 6.4.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 6.4.2. Cardiology Centers
- 6.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 6.4.3. Others
- 6.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key Country Dynamics
- 7.5.1.2. Competitive Scenario
- 7.5.1.3. Regulatory Framework
- 7.5.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key Country Dynamics
- 7.6.1.2. Competitive Scenario
- 7.6.1.3. Regulatory Framework
- 7.6.1.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6.3. Spain
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6.6. Denmark
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.6.8. Norway
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Competitive Scenario
- 7.6.8.3. Regulatory Framework
- 7.6.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key Country Dynamics
- 7.7.1.2. Competitive Scenario
- 7.7.1.3. Regulatory Framework
- 7.7.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.7.4. South Korea
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.7.5. Thailand
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.7.6. Australia
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory Framework
- 7.7.6.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key Country Dynamics
- 7.8.1.2. Competitive Scenario
- 7.8.1.3. Regulatory Framework
- 7.8.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.8.2. Mexico
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Mexico Coronary Artery Bypass Graft Market , 2018 - 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.9. MEA
- 7.9.1. MEA Coronary Artery Bypass Graft Market, 2018 - 2030 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory Framework
- 7.9.2.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory Framework
- 7.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Competitive Scenario
- 7.9.4.3. Regulatory Framework
- 7.9.4.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key Country Dynamics
- 7.9.5.2. Competitive Scenario
- 7.9.5.3. Regulatory Framework
- 7.9.5.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company /Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List Of Key Distributors And Channel Partners
- 8.3.2. Key Customers
- 8.3.3. Key Company Market Share Analysis, 2023
- 8.3.4. Medtronic, plc
- 8.3.4.1. Overview
- 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Terumo Corporation
- 8.3.5.1. Overview
- 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. Guidant Group
- 8.3.6.1. Overview
- 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. MAQUET Holding B.V. & Co.KG
- 8.3.7.1. Overview
- 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. Novadaq Technologies Inc.
- 8.3.8.1. Overview
- 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. KARL STORZ GmbH & Co. KG
- 8.3.9.1. Overview
- 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. Edwards Lifesciences Corporation
- 8.3.10.1. Overview
- 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.10.3. Product Benchmarking
- 8.3.10.4. Strategic Initiatives
- 8.3.11. Genesee Biomedical Inc.
- 8.3.11.1. Overview
- 8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.11.3. Product Benchmarking
- 8.3.11.4. Strategic Initiatives
- 8.3.12. Sorin Group
- 8.3.12.1. Overview
- 8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.12.3. Product Benchmarking
- 8.3.12.4. Strategic Initiatives